Search

Your search keyword '"L. Marelli"' showing total 105 results

Search Constraints

Start Over You searched for: Author "L. Marelli" Remove constraint Author: "L. Marelli"
105 results on '"L. Marelli"'

Search Results

51. Impact of Adherence (Compliance) to Oral Acyclovir Prophylaxis in the Recurrence of Herpetic Keratitis: Long-Term Results From a Pediatric Cohort.

52. Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center.

53. Normative positions towards COVID-19 contact-tracing apps: findings from a large-scale qualitative study in nine European countries.

54. Development of a bioeconomy monitoring framework for the European Union: An integrative and collaborative approach.

55. Latest evidences on meibomian gland dysfunction diagnosis and management.

56. A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System.

57. Thinking "ethical" when designing an international, cross-disciplinary biomedical research consortium.

58. The Ocular Surface Frailty Index as a Predictor of Ocular Surface Symptom Onset after Cataract Surgery.

59. Hepatic encephalopathy: a rare cause of focal seizures in chronic liver disease.

61. Variant data sharing by clinical laboratories through public databases: consent, privacy and further contact for research policies.

63. Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients.

64. A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.

65. The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.

66. Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma.

67. A pilot study comparing ESO-2 capsule endoscopy with conventional upper endoscopy for the assessment of uncomplicated heartburn and dyspepsia.

68. Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: trans-arterial radio-embolisation of HCC.

69. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?

70. Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.

71. Pegfilgrastim to accelerate neutrophil engraftment following peripheral blood stem cell transplant and reduce the duration of neutropenia, hospitalization, and use of intravenous antibiotics: a phase II study in multiple myeloma and lymphoma and comparison with filgrastim-treated matched controls.

72. Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis.

73. Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date.

74. Terlipressin therapy for renal failure in cirrhosis.

75. Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours.

76. Quantifying the impact of residential heating on the urban air quality in a typical European coal combustion region.

77. Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR.

78. Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patients.

79. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.

80. A comparison of four- versus three-pass transjugular biopsy using a 19-G Tru-Cut needle and a randomized study using a cassette to prevent biopsy fragmentation.

81. Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies.

82. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma.

83. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.

84. TACE versus TAE as therapy for hepatocellular carcinoma.

85. MELD and gender in the waiting list for liver transplantation.

86. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.

87. Autoimmune hepatitis associated with Kikuchi-Fujimoto's disease.

88. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements.

89. Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review.

90. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC.

92. Different methods of creatinine measurement significantly affect MELD scores.

93. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.

94. Repeated courses of transarterial embolization with polyvinyl alcohol particles: 'long life elixir' in a cirrhotic patient with unresectable hepatocellular carcinoma.

95. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias.

96. The transjugular route: the key hole to the liver world.

97. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

98. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies.

99. The low incidence of bacterial infections could be a protective factor against variceal bleeding per se in hemodynamic responders to propranolol.

100. Transjugular Intrahepatic Portosystemic Shunt (TIPS), the preferred therapeutic option for Budd Chiari syndrome associated with portal vein thrombosis.

Catalog

Books, media, physical & digital resources